Alamowitch Sonia, Eliasziw Michael, Barnett Henry J M
Stroke Unit, Department of Neurology, Tenon Hospital, AP-HP, Paris, France.
Stroke. 2005 Jan;36(1):27-31. doi: 10.1161/01.STR.0000149622.12636.1f. Epub 2004 Nov 29.
Perioperative risk and long-term benefit of carotid endarterectomy (CE) are not detailed in women with symptomatic internal carotid artery (ICA) stenosis. Our aim was to compare the efficacy of CE versus medical therapy in women and men with symptomatic ICA stenosis.
Data were taken from the North American Symptomatic Carotid Endarterectomy Trial (873 women, 2012 men) and the ASA and Carotid Endarterectomy trial (335 women, 813 men).
The 30-day perioperative risk of death was higher in women than in men (2.3% versus 0.8%, P=0.002). Higher perioperative risk of stroke and death was also observed (7.6% versus 5.9%) but not statistically significant. With > or =70% stenosis, the 5-year absolute risk reduction (ARR) in stroke from CE was similar between women (15.1%) and men (17.3%). With 50% to 69% stenosis, CE was not beneficial in women (ARR=3.0%, P=0.94), contrary to men (ARR=10.0%, P=0.02). Medically treated women had low risk for stroke. A stroke prognosis instrument (SPI-II) assigned points to 7 factors that identified higher risk for medically treated women: 3 points for hemispheric (not retinal) event, history of diabetes, previous stroke; 2 for age older than 70 years, stroke (not transient ischemic attack); 1 for severe hypertension, history of myocardial infarction. CE was beneficial only for 29.0% of women with 50% to 69% stenosis who had the highest total score of 8 to 15 (ARR=8.9%).
Women and men with > or =70% symptomatic stenosis had similar long-term benefit from CE, although the perioperative risks were higher for women. CE was not beneficial for women with 50% to 69% stenosis without other risk factors for stroke.
有症状的颈内动脉(ICA)狭窄女性患者的颈动脉内膜切除术(CE)围手术期风险及长期获益情况尚无详细报道。我们的目的是比较CE与药物治疗对有症状的ICA狭窄女性和男性患者的疗效。
数据取自北美症状性颈动脉内膜切除术试验(873例女性,2012例男性)以及美国麻醉医师协会(ASA)和颈动脉内膜切除术试验(335例女性,813例男性)。
女性30天围手术期死亡风险高于男性(2.3%对0.8%,P = 0.002)。围手术期卒中及死亡风险也较高(7.6%对5.9%),但无统计学意义。对于狭窄程度≥70%的患者,CE降低卒中风险的5年绝对风险降低率(ARR)在女性(15.1%)和男性(17.3%)中相似。对于狭窄程度为50%至69%的患者,CE对女性无益(ARR = 3.0%,P = 0.94),而对男性有益(ARR = 10.0%,P = 0.02)。接受药物治疗的女性卒中风险较低。一种卒中预后工具(SPI-II)根据7个因素为接受药物治疗的女性评定分数,这些因素表明其风险较高:半球性(非视网膜)事件、糖尿病史、既往卒中得3分;年龄大于70岁、卒中(非短暂性脑缺血发作)得2分;严重高血压、心肌梗死病史得1分。CE仅对狭窄程度为50%至69%且总分最高为8至15分的29.0%的女性有益(ARR = 8.9%)。
有症状的狭窄程度≥70%的女性和男性从CE中获得的长期获益相似,尽管女性围手术期风险较高。对于狭窄程度为50%至69%且无其他卒中危险因素女性,CE并无益处。